- Home
- GALT vs GNSS Comparison
GALT vs GNSS Comparison
Compare GALT & GNSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- GNSS
- Stock Information
- Founded
- GALT 2000
- GNSS 1992
- Country
- GALT United States
- GNSS United States
- Employees
- GALT N/A
- GNSS N/A
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- GNSS Consumer Electronics/Appliances
- Sector
- GALT Health Care
- GNSS Consumer Staples
- Exchange
- GALT Nasdaq
- GNSS Nasdaq
- Market Cap
- GALT 86.0M
- GNSS 98.9M
- IPO Year
- GALT N/A
- GNSS N/A
- Fundamental
- Price
- GALT $1.38
- GNSS $2.07
- Analyst Decision
- GALT Hold
- GNSS Strong Buy
- Analyst Count
- GALT 1
- GNSS 3
- Target Price
- GALT N/A
- GNSS $5.33
- AVG Volume (30 Days)
- GALT 177.7K
- GNSS 58.7K
- Earning Date
- GALT 05-19-2025
- GNSS 05-13-2025
- Dividend Yield
- GALT N/A
- GNSS N/A
- EPS Growth
- GALT N/A
- GNSS N/A
- EPS
- GALT N/A
- GNSS N/A
- Revenue
- GALT N/A
- GNSS $26,587,000.00
- Revenue This Year
- GALT N/A
- GNSS $121.93
- Revenue Next Year
- GALT N/A
- GNSS $68.26
- P/E Ratio
- GALT N/A
- GNSS N/A
- Revenue Growth
- GALT N/A
- GNSS N/A
- 52 Week Low
- GALT $0.73
- GNSS $1.65
- 52 Week High
- GALT $3.41
- GNSS $4.04
- Technical
- Relative Strength Index (RSI)
- GALT 49.81
- GNSS 44.92
- Support Level
- GALT $1.26
- GNSS $1.93
- Resistance Level
- GALT $1.63
- GNSS $2.28
- Average True Range (ATR)
- GALT 0.13
- GNSS 0.11
- MACD
- GALT 0.02
- GNSS 0.00
- Stochastic Oscillator
- GALT 37.50
- GNSS 36.84
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About GNSS Genasys Inc.
Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.